跳至主要内容
临床试验/NCT00609531
NCT00609531已完成1 期

Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders

University of North Carolina, Chapel Hill1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2007年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
12
试验地点
1
主要终点
Functional Magnetic Resonance Imaging

研究概览

简要总结

The purpose of this proof of concept study is to use functional magnetic resonance imaging and behavioral assessments to investigate the effect of citalopram on restricted repetitive behaviors in people with autism spectrum disorders.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
10 Years 至 55 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Ambulatory status (outpatient) at time of consent
  • Age 10-55 years
  • Clinical diagnosis of Autism Spectrum Disorder
  • IQ greater than or equal to 70
  • Score greater than 8 on Children's Yale-Brown Obsessive Compulsive Scale
  • Free of psychoactive medication for at least: one month for fluoxetine; two weeks for other SSRIs and neuroleptics; and five days for stimulants prior to MRI scanning [excepting stable doses (greater than three months duration) of anticonvulsant medication for seizure disorder]

排除标准

  • Age less than 10 years or greater than 55 years, at time of consent
  • Estimated IQ < 70
  • Uncontrolled epilepsy (seizure within 6 months prior to consent)
  • Presence of medical conditions that might interfere with participation, or where participation would be contraindicated
  • History of neurological injury: head trauma, poorly-controlled seizure disorder (seizure within the preceding six months), stroke, prior neurosurgery, or under the care of a neurologist or neurosurgeon as determined by interview
  • History of claustrophobia
  • Implanted or irremovable metal in the body (including certain tattoos and permanent make-up)
  • Current pregnancy (as verified by testing prior to both initial dose administration of citalopram or placebo and prior to magnetic resonance imaging) due to the risk that may be associated with SSRI treatment and magnetic resonance imaging on fetal health
  • Medical contraindications to SSRI therapy as determined by history (including induction of mania or hypomania during SSRI therapy, or known drug allergy)
  • Concomitant medication that would interfere with study participation
  • Prior history of citalopram treatment failure at appropriate doses and duration
  • Prior history of treatment failure to two previous SSRI trials at appropriate doses and duration
  • Ongoing need for psychoactive medication other than study medication [excepting stable doses (greater than three months duration) of anticonvulsant medication for seizure disorder, or diphenhydramine (Benadryl®)for sleep]

研究组 & 干预措施

Active

Experimental

Individuals with an Autism Spectrum Disorder receiving citalopram

干预措施: Citalopram (Drug)

Placebo

Placebo Comparator

Individuals with an Autistic Spectrum Disorder receiving placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Functional Magnetic Resonance Imaging

时间窗: two 2-hr scans

Clinicians Global Improvement Scale

时间窗: Upon study completion

次要结局

  • Childrens Yale-Brown Obsessive Compulsive Scale(Baseline, wks 2, 4, 8, endpoint)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gabriel Dichter

Associate Professor of Psychiatry

University of North Carolina, Chapel Hill

研究点 (1)

Loading locations...

相似试验

Functional MRI Evaluation of the Effect of... | 临床试验